These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 352667)

  • 21. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs.
    Collins AJ; Du Toit JA
    Br J Rheumatol; 1987 Aug; 26(4):295-8. PubMed ID: 3496934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [NSAIDs: a clinical pharmacological determination of their role in the drug treatment of rheumatic disorders].
    van Riel PL
    Ned Tijdschr Geneeskd; 1988 Nov; 132(48):2187-92. PubMed ID: 3264601
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial].
    Napoli A; Alderuccio B; Nannetti A
    Clin Ter; 1977 Dec; 83(5):541-7. PubMed ID: 343972
    [No Abstract]   [Full Text] [Related]  

  • 24. The disposition of sulindac.
    Duggan DE; Hare LE; Ditzler CA; Lei BW; Kwan KC
    Clin Pharmacol Ther; 1977 Mar; 21(3):326-35. PubMed ID: 300048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Third World conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992.
    Day RO; Brooks PM; Williams KM; Graham GG
    Agents Actions; 1993 Mar; 38(3-4):iv-viii. PubMed ID: 8213341
    [No Abstract]   [Full Text] [Related]  

  • 26. Non steroidal anti-inflammatory drugs. Risk factors versus benefits.
    Savvas P; Brooks PM
    Aust Fam Physician; 1991 Dec; 20(12):1726-9, 1732-3. PubMed ID: 1805774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
    Brogden RN; Pinder RM; Speight TM; Avery GS
    Drugs; 1977 Apr; 13(4):241-65. PubMed ID: 324748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal blood loss after a new anti-inflammatory drug, sulindac.
    Cohen A
    Clin Pharmacol Ther; 1976 Aug; 20(2):238-40. PubMed ID: 1084825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug therapy in rheumatology].
    Miehle W
    Fortschr Med; 1982 Sep; 100(36):1652-60. PubMed ID: 6292062
    [No Abstract]   [Full Text] [Related]  

  • 30. [Coumarin therapy during antirheumatism therapy with sulindac].
    Schenk H; Klein G; Haralambus I; Goebel R
    Z Rheumatol; 1980; 39(3-4):102-8. PubMed ID: 6968485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroscopic evaluation of the effects of nabumetone on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Petrillo M; Ardizzone S; Caruso I; Montone F
    Eur J Rheumatol Inflamm; 1991; 11(3):38-42. PubMed ID: 1365479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 33. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacotherapy of rheumatic diseases].
    Gaja A; Vykydal M
    Acta Univ Palacki Olomuc Fac Med; 1985; 108():295-300. PubMed ID: 3161288
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sulindac. Is it different from other non-steroidal anti-inflammatory agents?].
    Kvien TK; Berg KJ
    Tidsskr Nor Laegeforen; 1987 Mar; 107(9):862-4. PubMed ID: 3296307
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-inflammatory efficacy versus gastrointestinal safety: a dilemma resolved? Introduction.
    Bach GL
    Scand J Rheumatol Suppl; 1992; 96():5-6. PubMed ID: 1439625
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of a new non-steroidal anti-inflammatory agent, sulindac, on platelet function.
    Green D; Given KM; Ts'ao C; Whipple JP; Rossi EC
    Thromb Res; 1977 Feb; 10(2):283-9. PubMed ID: 322358
    [No Abstract]   [Full Text] [Related]  

  • 38. Nabumetone. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases.
    Friedel HA; Todd PA
    Drugs; 1988 May; 35(5):504-24. PubMed ID: 3293969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug therapy of inflammatory rheumatic diseases].
    Keitel W
    Z Arztl Fortbild (Jena); 1987; 81(9):439-41. PubMed ID: 3498268
    [No Abstract]   [Full Text] [Related]  

  • 40. [Celecoxib].
    Caballero E; Cárdenas E; Rodrigo A; Gurucharri N; Honorato J
    Rev Med Univ Navarra; 2001; 45(1):56-9. PubMed ID: 11488208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.